Immix Biopharma, Inc. · NASDAQ:IMMX
Immix Biopharma, Inc. shareholders
As of Jun 30, 2026, 106 institutions reported holding Immix Biopharma, Inc., 78.6% of its shares. Largest: Jupiter Topco LLC, Saturn V Capital Management LP and Eventide Asset Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Immix Biopharma, Inc. | Change | Filed |
|---|---|---|---|---|
| Jupiter Topco LLC | 9.78M | 13.7% | first report | Aug 14, 2026 |
| Saturn V Capital Management LP | 4.66M | 6.5% | +965K | Aug 14, 2026 |
| Eventide Asset Management, LLC | 3.89M | 5.4% | +1.34M | Aug 14, 2026 |
| Vanguard | 3.22M | 4.5% | +1.16M | Aug 13, 2026 |
| State Street | 3M | 4.2% | +2.81M | Aug 7, 2026 |
| BlackRock | 2.99M | 4.2% | +2.52M | Aug 7, 2026 |
| Deep Track Capital, LP | 2.77M | 3.9% | new | Aug 14, 2026 |
| Opaleye Management Inc. | 2.35M | 3.3% | new | Aug 14, 2026 |
| Millennium | 2.07M | 2.9% | +316K | Aug 14, 2026 |
| UBS | 1.94M | 2.7% | +1.86M | Aug 13, 2026 |